Stomach cancer gets a triple punch of therapy

Myriam Chalabi ()

Nature, 2021, vol. 600, issue 7890, 608-609

Abstract: Harnessing immune cells to target tumours is a growing trend. The results of a clinical trial combining such treatment with other standard therapies for gastric cancer have altered medical practice — and more changes are to come.

Keywords: Medical research; Cancer; Immunology (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-021-03458-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:600:y:2021:i:7890:d:10.1038_d41586-021-03458-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-021-03458-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().